Form 4: SAIC Interim CEO Acquires 19,649 Shares in Planned Grant
Insider Stock Acquisition
Science Applications International Corp's Interim CEO, James Reagan, is set to acquire 19,649 shares of common stock at a $0 price, increasing his direct beneficial ownership to 25,460 shares.
Summary
- James Reagan, Interim CEO and Director of Science Applications International Corp (SAIC), is acquiring 19,649 shares of common stock.
- The transaction date for this acquisition is December 5, 2025.
- The shares are being acquired at a price of $0 per share, indicating a grant, likely related to compensation or vesting.
- Following this transaction, Mr. Reagan will directly beneficially own a total of 25,460 shares of SAIC common stock.
- The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 6
Explanation: The sentiment is mildly positive as an insider is increasing their stake, even if it's a compensation-related grant. This generally signals confidence in the company's future performance and aligns management's interests with shareholders. There are no negative aspects reported.
Positives
- An insider, the Interim CEO and Director, is increasing their stake in the company, which can be viewed as a sign of confidence.
- The acquisition of shares at a $0 price suggests a compensation-related grant, aligning management's interests with shareholders.
Future Outlook
The filing reports a future planned acquisition of shares by an insider, indicating a pre-arranged compensation or equity plan set to execute on December 5, 2025.
Industry Context
This insider transaction is a routine disclosure for executive compensation and equity ownership, common across all industries, particularly in the defense and government services sector where SAIC operates. It reflects standard corporate governance practices for aligning executive incentives.
Comparison to Industry Standards
- The acquisition of shares by an executive as part of a compensation package (indicated by the $0 price) is a standard practice in corporate America, aligning executive interests with shareholder value creation.
- The use of a Rule 10b5-1 plan for pre-arranged transactions is a common and accepted method for insiders to manage their equity holdings while avoiding accusations of trading on material non-public information.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan Disclosure | The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | 12/05/2025 | Enhances transparency regarding insider trading activities and provides a legal framework for executives to trade company stock without violating insider trading laws, promoting good corporate governance. |
Stakeholder Impact
- Shareholders: The increase in insider ownership, even through a grant, can be seen as a positive signal, potentially aligning management's incentives with shareholder value creation.
- Employees: Standard executive compensation practices, including equity grants, are part of the overall compensation structure, which can influence employee morale and retention at leadership levels.
Next Steps
- The acquisition of 19,649 shares of common stock by James Reagan is scheduled to occur on December 5, 2025.
Key Dates
| Date | Description |
|---|---|
| 12/05/2025 | Date of transaction for the acquisition of 19,649 shares of common stock by James Reagan. |
| 12/09/2025 | Date the Form 4 was signed by Hilary L. Hageman, Attorney-in-fact for James Reagan. |
Recommendation
holdThis Form 4 filing reports a routine, pre-planned acquisition of shares by an insider as part of compensation, which is generally a neutral to slightly positive event. It does not contain information significant enough to warrant a change in investment recommendation based solely on this disclosure. The transaction aligns management's interests with shareholders but doesn't provide new fundamental insights into the company's operational or financial performance that would drive a 'buy' or 'sell' decision.
Keywords
SAIC, Science Applications International Corp, James Reagan, Insider Trading, Stock Acquisition, Form 4, CEO, Director, Equity Grant, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.